Clinical Trial Update: Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study of Acoramidis in transthyretin cardiac amyloidosis (ATTR-CM) assessing real-world efficacy and associations wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Cardiac Amyloidosis

Drugs mentioned

• Acoramidis (acoramidis)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Transthyretin-type Cardiac Amyloidosis | Phase 4 | Status: RECRUITING